Synbio Tech 1295.TWO · TWD

Its shares trade on Taipei Exchange under the ticker 1295.TWO. It has been listed since 13 December 2023. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.04bn and net income of TWD 176.0m. At that date it held total assets of TWD 3.09bn and shareholders' equity of TWD 1.33bn.

Synbio Tech Inc is a TW-based company operating in Biotechnology industry. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2023-12-13. Synbio Tech Inc is a Taiwan-based company mainly engaged in the development and application of lactic acid bacteria. The firm is engaged in the research and development, manufacture and sale of lactic acid bacteria. The firm's main products are lactic acid bacteria powder, starter culture, fermentation broth, beverages, among others. The firm's main products are used in human health care, green breeding of livestock and aquatic products, plant preservation, beverages and fermented products, among others. The firm's main product applications include functional human health foods, fermented milk drinks, pet food, livestock and aquaculture feed additives, among others.

Figures and description from our data supplier, not checked against the company's own report.

• Lianchuan YangChairman of the Board, since 2023
• Sanlian YangChief Executive Officer, Chief Operating Officer, General Manager, Director
• Xiuru ZhangDeputy General Manager-Accounting Division, Head of Finance, Corporate Governance Officer, since 2024
• Jiangshui JiangDirector
• Zhaoming LiuDirector
• Guoxiong ChenIndependent Director
• Guanyou LaiIndependent Director
• Ms. Shau-Mei OuIndependent Director
• Mr. Mingbang ZhaIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.